China Pharma Holdings
CPHI
3 hedge funds and large institutions have $43K invested in China Pharma Holdings in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.06% more ownership
Funds ownership: 0.04% → 0.1% (+0.06%)
42% less capital invested
Capital invested by funds: $73.8K → $43K (-$30.8K)
57% less funds holding
Funds holding: 7 → 3 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$6.28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$211 |
Top Sellers
| 1 |
Millennium Management
New York
|
-$33.6K |
| 2 |
JP Morgan Chase
New York
|
-$7.92K |
| 3 |
VF
Virtu Financial
New York
|
-$6K |
| 4 |
HF
HRT Financial
New York
|
-$2K |
| 5 |
FCT
First Community Trust
Dubuque,
Iowa
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $35K | +$26.8K | +6,106 | +184% |
|
|
TSS
2
Two Sigma Securities
New York
| $5.3K | +$6.28K | +1,428 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $2.72K | +$211 | +48 | +7% |
|
|
4
Millennium Management
New York
| – | -$33.6K | -5,561 | Closed |
|
|
5
JP Morgan Chase
New York
| – | -$7.92K | -1,308 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$6K | -934 | Closed |
|
|
HF
7
HRT Financial
New York
| – | -$2K | -421 | Closed |
|
|
FCT
8
First Community Trust
Dubuque,
Iowa
| – | -$18 | -3 | Closed |
|
CPHI Hedge Fund Activity: Q1 2024 in Review
3 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2024, worth a combined $43K — down 42% from $73.8K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CPHI and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, adding an estimated $26.8K. The largest seller was Millennium Management, exiting entirely with an estimated $33.6K sold.
- 3 institutional investors held China Pharma Holdings (CPHI) as of Q1 2024, down from 7 in Q4 2023.
- Funds reported $43K of China Pharma Holdings stock for Q1 2024, down 42% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q1 2024 and 5 closed out, a net change of -4 holders.
- The largest China Pharma Holdings buyer in Q1 2024 was Citadel Advisors, an estimated $26.8K added.
- The largest China Pharma Holdings seller in Q1 2024 was Millennium Management, an estimated $33.6K sold.
Based on aggregated 13F filings for Q1 2024.